Forte Biosciences, Inc.

Informe acción NasdaqCM:FBRX

Capitalización de mercado: US$6.1m

Dividendos de Forte Biosciences

Dividendo controles de criterios 0/6

Forte Biosciences does not have a record of paying a dividend.

Información clave

n/a

Rentabilidad por dividendo

-404.4%

Rendimiento de la recompra

Rendimiento total para el accionista-404.4%
Rendimiento futuro de los dividendosn/a
Crecimiento de los dividendosn/a
Próxima fecha de pago de dividendosn/a
Fecha ex dividendon/a
Dividendo por acciónn/a
Ratio de pagon/a

Últimas actualizaciones de dividendos

No hay actualizaciones

Recent updates

We're A Little Worried About Forte Biosciences' (NASDAQ:FBRX) Cash Burn Rate

Jul 17
We're A Little Worried About Forte Biosciences' (NASDAQ:FBRX) Cash Burn Rate

Is Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans?

Mar 14
Is Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans?

Large Forte Biosciences shareholder scolds company board of directors

Aug 24

We're Hopeful That Forte Biosciences (NASDAQ:FBRX) Will Use Its Cash Wisely

Aug 17
We're Hopeful That Forte Biosciences (NASDAQ:FBRX) Will Use Its Cash Wisely

Forte Biosciences: Lots Of Clinical Risk Ahead And A Questionable Business Plan

Aug 16

Forte Biosciences large shareholders make demands for company's future

Jul 07

We Think Forte Biosciences (NASDAQ:FBRX) Needs To Drive Business Growth Carefully

Dec 23
We Think Forte Biosciences (NASDAQ:FBRX) Needs To Drive Business Growth Carefully

Forte Biosciences files for $300M mixed shelf offering

May 28

Are Insiders Buying Forte Biosciences, Inc. (NASDAQ:FBRX) Stock?

Mar 13
Are Insiders Buying Forte Biosciences, Inc. (NASDAQ:FBRX) Stock?

Do Institutions Own Forte Biosciences, Inc. (NASDAQ:FBRX) Shares?

Jan 19
Do Institutions Own Forte Biosciences, Inc. (NASDAQ:FBRX) Shares?

Forte Biosciences: FB-401 Potentially Best-In-Class In Atopic Dermatitis

Dec 18

Who Has Been Buying Forte Biosciences, Inc. (NASDAQ:FBRX) Shares?

Nov 25
Who Has Been Buying Forte Biosciences, Inc. (NASDAQ:FBRX) Shares?

Forte Biosciences readies equity offering

Oct 28

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: Insufficient data to determine if FBRX's dividends per share have been stable in the past.

Dividendo creciente: Insufficient data to determine if FBRX's dividend payments have been increasing.


Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Forte Biosciences vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de FBRX con la del mercado?
SegmentoRentabilidad por dividendo
Empresa (FBRX)n/a
Suelo de mercado 25% (US)1.5%
Techo de mercado 25% (US)4.5%
Media de la industria (Biotechs)2.2%
Analista de previsiones (FBRX) (hasta 3 años)n/a

Dividendo destacado: Unable to evaluate FBRX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Alto dividendo: Unable to evaluate FBRX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Pago de beneficios a los accionistas

Cobertura de los beneficios: Insufficient data to calculate FBRX's payout ratio to determine if its dividend payments are covered by earnings.


Pago en efectivo a los accionistas

Cobertura de flujo de caja: Unable to calculate sustainability of dividends as FBRX has not reported any payouts.


Descubre empresas que pagan buenos dividendos